Latest market price
56.27
+1.87+3.44%
OverviewShort InterestFilings
MBXQT90MBX Biosciences, Inc. Common Stock·NASDAQ
56.27+3.44%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 22, 20263Initial statement of beneficial ownership
Oct 22, 20264Statement of changes in beneficial ownership
Oct 22, 20268-KCurrent report
Aug 27, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 10, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 13, 20268-KCurrent report
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 24, 2026SC 13GBeneficial ownership statement (passive)
Jun 12, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
#1 / 25 of 204
Page
▼
/ 9